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Abstract
Early detection of coronary heart disease (CHD) has the potential to prevent the millions of
deaths that this disease causes worldwide every year. However, there exist few automatic
methods to detect CHD at an early stage. A challenge in the development of these methods is
the absence of relevant datasets for their training and validation. Here, the ten Tusscher-Pan-
filov 2006 model and the O’Hara-Rudy model for human myocytes were used to create two
populations of models that were in concordance with data obtained from healthy individuals
(control populations) and included inter-subject variability. The effects of ischemia were sub-
sequently included in the control populations to simulate the effects of mild and severe ische-
mic events on single cells, full ischemic cables of cells and cables of cells with various sizes of
ischemic regions. Action potential and pseudo-ECG biomarkers were measured to assess
how the evolution of ischemia could be quantified. Finally, two neural network classifiers were
trained to identify the different degrees of ischemia using the pseudo-ECG biomarkers. The
control populations showed action potential and pseudo-ECG biomarkers within the physio-
logical ranges and the trends in the biomarkers commonly identified in ischemic patients were
observed in the ischemic populations. On the one hand, inter-subject variability in the ische-
mic pseudo-ECGs precluded the detection and classification of early ischemic events using
any single biomarker. On the other hand, the neural networks showed sensitivity and positive
predictive value above 95%. Additionally, the neural networks revealed that the biomarkers
that were relevant for the detection of ischemia were different from those relevant for its clas-
sification. This work showed that a computational approach could be used, when data is
scarce, to validate proof-of-concept machine learning methods to detect ischemic events.
Introduction
Coronary heart disease (CHD) is an occlusion of the vessels that irrigate the heart. Even
though sometimes CHD is asymptomatic, it is very likely to cause ischemia and infarction.
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Current clinical guidelines suggest to target personalized therapies to patients at high risk [1]
to reduce the deaths by CHD, but there exist few automatic methods for individual risk assess-
ment. Consequently, clinicians rely on visual ECG inspection, which has been proven to be
affected by personal bias and fatigue [2]. Furthermore, inter-subject variability plays a defining
role when assessing this risk: a healthy-looking patient can suddenly die of CHD and a patient
considered at high risk can live many years without showing indications of the underlying
pathology. Moreover, CHD often presents itself as a ‘silent’ disease, showing no symptoms,
and a heart attack or a stroke is the first warning [3]. Consequently, assessing the individual
risk of suffering from coronary heart disease is today one of the most pressing issues in bio-
medical engineering.
The study of the effects of ischemia in-vivo in humans is often affected by many methodo-
logical factors [4] and is limited by small cohorts of patients because of the invasiveness of the
necessary acquisitions and scarcity of suitable individuals [5, 6]. Indeed, there are very few
public electrocardiogram (ECG) recordings databases specifically acquired for the study of
ischemia, and the few that exist contain a limiting number of caveats. For instance, the STAF-
FIII database [7–9], one of the most relevant ECG databases for the study of ischemia to date,
contains just 104 patients, aged 60.77 ± 11.57 years, with pre-existing cardiac conditions and
varied morphological features (e.g. location of myocardial infarction or which artery was
occluded); these factors, commonly found in clinical acquisitions concerning ischemia, com-
promise the clinical extrapolation of the findings of ischemia studies in humans [4]. Moreover,
the lack of relevant datasets has precluded the development of machine learning methods for
the detection of early-stage ischemic events because they fail to generalize. Indeed, machine
learning techniques, in the context of ECG analysis, have mostly been developed for the detec-
tion of abnormal cardiac rhythms, as can be consulted in the recent review by Lyon et al. [10],
or for the detection and localization of myocardial infarction, as has been summarized by
Acharya et al. [11]; to the best of our knowledge, there is no machine learning technique
applied to the early detection of ischemia that has successfully generalized to clinical practice.
However, previous research has already highlighted that computer simulations could be used
to generate large datasets suitable for the training of machine learning algorithms [10]. This
paper was motivated by the hypothesis that a computational study, prior to a clinical trial,
could be beneficial to the development of ischemia-detection methods.
Recent studies have investigated the effects of ischemia through mathematical models of
cardiac electrophysiology (EP) [12–15]. The introduction of ischemia in computational mod-
els has allowed the study of its effects in single cells, cables of cells, slabs of tissue and whole
heart models. Some whole-heart in-silico studies have also calculated and analyzed ECG signals
from ischemic hearts [16–18]. An advantage of these computational studies, over their experi-
mental counterparts, is that the severity and size of the ischemic event can be modulated in
detail. Moreover, computational simplifications (i.e. 1D cable of cells or 2D slab of tissue
instead of 3D heart geometry) already enable the study of pathological behavior [15, 19] with-
out the need of extensive computational resources. However, hitherto, computational studies
of ischemia have not included the inherent variability that is naturally observed in humans at
the cellular electrophysiology level [20]. Including variability in mathematical models for
ischemia could enable the creation of simulated databases that may be large enough for the
training of machine learning algorithms.
To analyze the effects of inter-subject variability at the cellular level, recent research in car-
diac EP has resorted to ‘experimentally-calibrated population of models’ (ePoM). The ePoM
approach has been successfully applied to investigate the effects of variability in the EP proper-
ties of myocytes, both in physiology and pathology [21–25]. Previous population-based studies
have explored how EP properties are affected by ionic current variabilities during acute
Modeling and machine learning for ECG feature engineering
PLOS ONE | https://doi.org/10.1371/journal.pone.0220294 August 12, 2019 2 / 21
Trust through the Senior Research Fellowship
“Exploring the Unknowable Using Simulation:
Structural Uncertainty in Multiscale Models”
(Fellowship number RF-2015-482). VD is also
supported by the Wellcome/EPSRC Centre for
Interventional and Surgical Sciences (WEISS)
(203145Z/16/Z). BR and XZ are supported by BR’s
Wellcome Trust Senior Research Fellowship in
Basic Biomedical Sciences and the European
Union’s Horizon 2020 research and innovation
programme under Grant Agreement No. 675451
(CompBioMed project). The funders had no role in
study design, data collection and analysis, decision
to publish, or preparation of the manuscript.
Competing interests: The authors have declared
that no competing interests exist.
ischemia [26, 27], but population-based techniques are yet to be adapted to create populations
of ischemic ECG signals that include inter-subject variability.
This work presents a methodology that intends to prove the feasibility of ischemia classifi-
cation using machine learning techniques. Here, simulated data, constructed using an ePoM
approach, is used to validate proof-of-concept classifiers as a step prior to training with clinical
data; the motivation behind this is that a classifier that does not work on ideal data will be
uncapable of generalizing to a real-life environment. Morevover, this work hypothesized that
training on simulated data could highlight which ECG biomarkers provide more information
about the presence of ischemia. Consequently, an initial computational study could be used to
guide the complicated analysis of real ECG signals. Observe that this does not mean that the
discoveries from the computational study would be directly translatable to a clinical setup. As
with any in silico study, the insights found through this framework would then require clinical
validation.
Materials and methods
Models of human cellular electrophysiology
In this work, cardiac EP was simulated with the two most widely used, state of the art, models.
First, the ten Tusscher-Panfilov 2006 (TP06) model [28, 29] provided an efficient implementa-
tion, capable of reproducing the effects of ischemia. For the purpose of comparison, the
O’Hara-Rudy (ORd) model for the undiseased human cardiac ventricular action potential [30]
was also used because it is the most detailed and thoroughly validated description of cardiac
EP to date. However, since the ORd model is more complex and, consequently, computation-
ally more expensive than the TP06, it was only used during the modeling part of this work and
not for the machine learning section. The ORd model is not capable of reproducing conduc-
tion of action potentials (AP) under severe hyperkalemic conditions, so the equations for the
INa h gates of the ORd model were modified as suggested by Passini et al. [31] and the time
constants of the h and j gates were modified as prescribed by Dutta et al. [15]. Additionally, the
sodium conductance was modified to GNa = 47 mS/μF to compensate for the changes in mag-
nitude in INa that these new definitions produce.
Experimentally-calibrated populations of models
Here, variability was investigated by means of an ‘experimentally-calibrated population of
models’ (ePoM) approach. The population of models generation and calibration process has
been explained in previous, successful, population-based studies in cardiac EP modeling [20,
24, 27]. One ePoM was created with each model using the experimental data presented in
Table 1, obtained from the work by Morgan et al. [32]. These EP measurements were made on
patients undergoing an electrophysiological study that revealed no evidence of heart disease;
therefore, these populations were called Control ePoM.
In short, each Control ePoM was generated as follows. First, as explained by Muszkiewicz at
al. [20], all the maximal conductances and peak currents of the model in question were allowed
to vary between 0 and 2 times their baseline value and 10000 different parameter combinations
were selected using Latin Hypercube Sampling [33]. Then, using each parameter combination,
a single cell simulation was performed at 430 ms and 600 ms cycle length (CL) to match the
experimental calibration data. Each model was stimulated for 200 beats, needed to reach steady
state conditions, and only the last beat was saved for further analysis. Once the 10000 simula-
tions were completed, models were excluded from the study using the following criteria: action
potential amplitude less than 0, resting membrane potential larger than -64 mV and upstroke
time exceeding 10 ms. The exclusion criteria correspond to measurements that are outside of
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the range that is considered healthy. Finally, from the remaining models, only those that pro-
duced action potential duration at 90% repolarization (APD90) within the range specified in
Table 1, for both CL, were kept; the resulting population of models gives the single cell Control
ePoM.
To investigate variability in the conduction velocity and pECG biomarkers, each parameter
set contained in the single cell Control ePoM was used to simulate AP propagation on a cable
of cells. The population that resulted from these simulations was the cable Control ePoM. Each
cable was formed by a homogeneous array of cells, its length was L = 2 cm, the inter-cell sepa-
ration was Δl = 0.02 cm and the cell-to-cell conductivity was D = 1.171 � 10−3 cm2/s. Stimula-
tion was provided at one end of the cable (l = 0) at CL = 600 ms and for 30 beats to guarantee a
steady state response; as before, only the last beat was saved. Pseudo-ECG (pECG) signals were
calculated using the steady state response of the cables of cells using the equation provided by
Gima and Rudy [19, 34]:
Feðl0Þ ¼ A
R
ð  rVÞ r
1
l   l0
� �
dl ð1Þ
where Fe(l0) is the pECG observed on a virtual probe placed at position l0, A is a constant
which depends on the radius of the fiber and the intra- and extra-cellular conductivities and V
is the steady state AP on the cable of cells. Pseudo-ECGs were calculated on a virtual probe 2
cm away from the end of the cable (l = 4 cm) and only cells 15 to 85 were used to calculate the
pECG; the latter prevents stimulation and boundary interference on the pECG signal [19].
Furthermore, A was set to 1 because the scaling of the pECG was not relevant for this study; in
particular, the amplitude of the ECG is irrelevant in the design of predictive biomarkers
because it depends on the size and constitution of the patient’s chest. As will be explained later,
the pECG amplitude will be studied as it varies in time, factoring out the effects of the differ-
ences in chest morphology.
Modeling variability in acute ischemia
The parameters contained in the Control ePoMs were then used to investigate variability in EP
measurements under acute ischemia. Namely, each parameter set was used to solve a model
that included the main effects of ischemia as suggested by previous work [15]. First, hyperkale-
mia was reproduced by increasing the extracellular potassium concentration ([K+]o). Second,
acidosis was included in the model by inhibiting the fast-inward sodium (INa) and L-type cal-
cium (ICaL) currents through a constant (finhib) that multiplied their computed value. Finally,
hypoxia was modeled by including an additional ionic current that reproduces the effect of
ATP-sensitive channels (Ik(ATP)); the definition provided by Dutta et al. [15] was implemented:
IkðATPÞ ¼ fkðATPÞ � GkðATPÞ �
½Kþ�o
½Kþ�on
 !0:24
� ðV   EkÞ ð2Þ
where the amplitude of the current depends on the ratio between the extracellular potassium
concentration ([K+]o) and its control value (½Kþ�on ¼ 5:4 mM), the transmembrane potential
Table 1. Monophasic action potential duration (MAPD) data used for calibration of the Control ePoM.
Drive cycle length MAPD range
430 ms 170–240 ms
600 ms 195–290 ms
https://doi.org/10.1371/journal.pone.0220294.t001
Modeling and machine learning for ECG feature engineering
PLOS ONE | https://doi.org/10.1371/journal.pone.0220294 August 12, 2019 4 / 21
(V) and the potassium equilibrium potential (Ek). The value of the channel conductance (Gk
(ATP)) was fixed at 0.064 mS/μF and a scaling factor (fk(ATP)) was used to regulate the severity of
the ischemic event.
To investigate the evolution in time of acute ischemic events, alongside variability, two
ischemic severities were simulated using the parameters specified in Table 2. The Severe
parameters were obtained from the previous work by Dutta et al. [15], and the Mild condition
was assumed to be at a mid-point between the absence of ischemic effects and the severe ische-
mic parameters.
Single cell simulations were performed, with the same simulation parameters as before, to
construct single cell Mild and Severe ePoMs. Then, several cable simulations were performed,
allowing one to investigate the influence of the size of the ischemic region on EP biomarkers.
In each cable of cells, an ischemic region was defined around the middle of the fiber, with a
transition region of 0.1 cm in length at either end of the ischemic region. In the transition
region the ischemic parameters were varied linearly from their ischemic value (Mild or Severe)
to the Control value. Four sizes of the ischemic region were investigated (i.e. 0.5 cm, 1 cm, 1.5
cm and 2 cm), one cable Mild ePoM and Severe ePoM was produced for each. Each cable simu-
lation was conducted using the same simulation parameters detailed before. Because of the
long computational times, the ORd model was used only to perform the cable Mild (2 cm) and
Severe (2 cm) ePoMs simulations.
AP and pECG biomarkers
The effects of variability in EP properties under acute ischemic conditions were investigated
using four action potential biomarkers and six pECG biomarkers. First, Action Potential
Amplitude (APA) was measured as the amplitude of the transmembrane potential at the end
of the initial depolarization phase; the amplitude was measured with respect to zero. Then,
Action Potential Duration (APD90) was measured as the time when the transmembrane
potential was at 10% of the APA. Also, the Resting Membrane Potential (RMP) was measured
as the transmembrane potential at the end of the cycle. Additionally, only in the cable simula-
tions, the Conduction Velocity (CV) was calculated as:
CV ¼
l2   l1
ATðl2Þ   ATðl1Þ
ð3Þ
where l2 = 1.6 cm, l1 = 0.4 cm and the Activation Time (AT(l)) at each of those points was
obtained as the time instant when the transmembrane potential surpassed zero. Subsequently,
from each cable simulation, the following pECG biomarkers were measured: (A) QRS duration
as the time difference between the end and the beginning of the QRS complex, (B) QT interval
as the time difference between the start of the QRS complex and the end of the T wave, (C) ST
deviation as the amplitude of Fe at the mid-point between the end of the QRS complex and the
beginning of the T wave, (D) T wave duration as the time difference between the start and the
end of the T wave, (E) QRS amplitude was measured as the maximum value observed during
the QRS complex, and (F) T wave amplitude as the maximum value observed in Fe during the
Table 2. Parameter sets for simulating the different stages of ischemia.
Parameter Mild Severe
fk(ATP) 0.1 0.2
finhib 0.875 0.75
[K+]o 6.25 mM 9.0 mM
https://doi.org/10.1371/journal.pone.0220294.t002
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T wave. An example of a pECG signal and the biomarkers can be observed in Fig 1. The onset
and end of the waves were taken as the time instant when Fe reached 10% of their peak values
at the relevant side of the wave.
Additionally, the ratio of change of each biomarker with respect to its control value, as
ischemia developed, was calculated as:
b0 ¼
bI
bC
ð4Þ
where b0 was the ratio of change of a given biomarker, bC was the biomarker calculated from
the pECG of a control model and bI was the biomarker calculated from the pECG of the same
model after applying an ischemic variation (Mild or Severe). Observe that by calculating the
ratio of change of the amplitude of the pECG, the effect of the electrical signal propagating
through the chest (i.e. K in the pECG calculation) is factored out; hence, the study of the tem-
poral evolution of the QRS and T wave amplitudes is relevant.
Automatic classification of ischemic severity
Artificial Neural Networks (ANN) were trained to detect and classify the evolution of an ische-
mic event. The ANNs were fully-connected multi-layer perceptrons, with rectified linear hid-
den units and sigmoid output units. A complete exposition of the machine learning
techniques used here has been made by Goodfellow et al. [35] and complete details of the
Fig 1. Pseudo ECG signal with its measured biomarkers. The pECG signal was calculated from a cable of TP06 cells.
The biomarkers shown are: (A) QRS duration, (B) QT interval, (C) ST deviation, (D) T wave duration, (E) QRS
amplitude and (F) T wave amplitude.
https://doi.org/10.1371/journal.pone.0220294.g001
Modeling and machine learning for ECG feature engineering
PLOS ONE | https://doi.org/10.1371/journal.pone.0220294 August 12, 2019 6 / 21
implementations made for this work are provided in S1 File. Three datasets were used to train
the models: the first group contained the pECG features measured from the cable Control
ePoM of TP06 models, the second contained the pECG features from the cable Mild (2 cm)
ePoM of TP06 models and the third group contained the pECG features from the cable Severe
(2 cm) ePoM of TP06 models. Two different learning structures are proposed in this work.
The first approach (ANN1) was trained to discriminate between the three different popula-
tions of virtual signals (Control, Mild, Severe), which were encoded using one-hot vectors. This
network was designed to use the magnitudes of the pECG biomarkers as inputs. Propagation
through the network resulted in the activation (oi = 1) of one of three output neurons (o1, o2 or
o3) whilst the other two neurons remained inactive (oi = 0). Then, classification was made by
assigning each activation patterns (o1o2o3 = 100, o1o2o3 = 010, o1o2o3 = 001) to each of the pop-
ulations (Control, Mild, Severe) respectively.
The second approach was a cascade of two networks. The first network (ANN21) would dis-
criminate between a non-ischemic (Control) and an ischemic (Mild or Severe) signal using the
magnitudes of the pECG biomarkers. The second network (ANN22) distinguished between the
Mild and Severe ischemic signals using the ratio of change between the biomarkers. Each of
these networks had a single output neuron.
All the networks were trained following the same procedure. First, the examples were ran-
domly divided into a training set and an evaluation set, containing 75% and 25% of the data,
respectively. The training set was then used to perform a 10-fold cross-validation. In each of
the cross-validation iterations the weights of the ANN were initialized to random small values.
Then, all the cross-validation training examples were propagated through the network and the
cost was calculated using a binary cross-entropy function regularized using weight decay. The
derivative of the cost with respect to each of the network’s weights was calculated using back-
propagation and the weights were updated following the gradient descent. The weights that
performed best during the cross-validation were tested in the evaluation set, the performance
on this set was the one reported in the results. Complete details about the implementation of
the neural networks and the training algorithm are provided as Supporting Information (S1
File).
Each ANN was repeatedly trained, varying the number of hidden layers and hidden neu-
rons per layer, until the best performing network (in the evaluation set) was found. The perfor-
mance of each trained model was measured using the Positive Predictive Value (PPV) and
Sensitivity (Se) and the ANNs were compared using the F1-score. The hyperparameter search
method implemented here is largely similar to those that have been used to achieve state-of-
the-art performances in ECG classification [36–39]; to date, this is the best known methodol-
ogy to find generalizable hyperparameters. Finally, after finding the optimal topology for each
network, the relative importance of the input features in each classification task was found
using the approach explained by Garson [40] and Goh [41].
To provide a baseline value for the classification performance, a logistic regression classifier
was also trained. This was done in order to establish that the classification on the pECG signals
was not trivial and to clearly illustrate that complex non-linear relationships exist in the data.
The results from the logistic regression are part of the Supporting Information.
Implementation details
The solutions to the TP06 and ORd models were implemented in Matlab (R2017a) and solved
using ode15s. The Matlab solver uses a variable order method to solve stiff ordinary differen-
tial equations, it was configured to use a maximum relative tolerance of 10-3, a maximum abso-
lute tolerance of 10-6 and the default maximum step size (i.e. 0.1|CL|). This last option is
Modeling and machine learning for ECG feature engineering
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recommended by Matlab because reducing it can significantly slow down the routine; more-
over, the results had sufficient quality without limiting the maximum step size of the solver.
The implementation of both models was based on the codes provided by the authors of the
original papers (TP06: http://www-binf.bio.uu.nl/khwjtuss/SourceCodes/, ORd: http://
rudylab.wustl.edu/research/cell/code/AllCodes.html). The implementations were adapted to
simulate populations of models and ischemia as explained in the previous sections. The reac-
tion-diffusion system used for the cable simulations was solved using the numerical method of
lines [42]. Namely, the spatial derivative was discretized using a central difference approxima-
tion that converts the PDE system into an ODE system to be solved using ode15s. These rou-
tines were deployed in the UCL Computer Science cluster (hpc.cs.ucl.ac.uk) to
compute all the models needed to build the previously described populations of models.
The artificial neural network routines were implemented in Python (3.6.1), using NumPy
(1.13.1) and Theano (0.9.0). The training and evaluation was made in a DELL Precision Tower
5810 with an Intel Xeon E5-1620 CPU, 32GB of RAM, and an Ubuntu (16.04 LTS) operating
system.
Results
AP and pECG biomarkers of Control populations
The calibration process resulted in a single cell Control population of 2044 TP06 models and
2226 ORd models. The values of the biomarkers measured from the single cell Control AP
traces, at 600 ms cycle length, and from the pECGs calculated from the cable Control ePoMs
are presented in Table 3. The pECG biomarkers measured as magnitudes are not presented
because, as explained in the methods, these markers were only interesting to observe as ratio of
change with respect to the control value.
AP biomarkers of ischemic populations
Fig 2 shows the magnitude of the AP biomarkers of the single cell Mild and Severe ePoMs.
Save for a small difference in magnitude, both models showed similar results: the single cell
Mild ePoMs were characterized by a decrease in APD90, an increase in RMP and a decrease in
APA. These variations were accentuated when the biomarkers were measured in the single cell
Severe ePoM. The trends observed in the AP biomarkers of the single cell simulations were
also observed in the AP biomarkers measured from the cables of cells (see Fig 3). Additionally,
there was a minor reduction in conduction velocity in the cable Mild (2 cm) ePoMs, but the
reduction became evident when the CV was measured in the cable Severe (2 cm) ePoMs.
Table 3. AP and pECG biomarkers measured from the Control ePoM. The values are presented as mean and stan-
dard deviation.
Biomarker TP06 ORd
APD90 (ms) 233.28 ± 34.87 227.73 ± 19.83
APA (mV) 52.47 ± 16.35 37.90 ± 7.08
RMP (mV) −84.91 ± 2.33 −87.70 ± 0.92
CV (cm/s) 60.80 ± 15.17 50.14 ± 6.34
QT interval (ms) 264.30 ± 26.84 273.03 ± 26.19
QRS duration (ms) 22.12 ± 14.50 29.04 ± 10.05
T wave duration (ms) 33.78 ± 12.21 50.56 ± 28.76
https://doi.org/10.1371/journal.pone.0220294.t003
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pECG biomarkers of ischemic populations
A qualitative assessment of the pECG signals a clear reduction in the QT interval, an increase
in the length of the T wave and ST segment deviation from the isoelectric line, all of which are
well-known markers for ischemia in ECG recordings. Additionally, an increase in the QRS
complex duration under Severe ischemic conditions for all signals was observed. However, this
last observation was only evident in some of the signals that simulated Mild ischemia; this is a
clear manifestation of inter-subject variability. Examples of the pECG traces obtained in this
work are provided as Supporting Information (S2 File).
The aforementioned trends can be quantitatively observed in Fig 4, these biomarkers were
measured from the 2 cm ischemic cables of cells. The only biomarker that showed a clear dif-
ference between the Control and the Mild cases was the QT duration, all the other biomarkers
showed evident deviations from the Control biomarkers only in the Severe ischemic case. The
main trends that underpinned the presence of a Severe ischemic event were an increase in T-
wave magnitude, pronounced ST deviation, reduced QRS amplitude, reduced QT duration,
increased QRS duration and an increase in T wave duration—they were equivalent in the
results from both models. Furthermore, Fig 5 shows that the previously mentioned trends in
the magnitudes of the biomarkers were more evident when analyzing their ratio of change.
The influence of varying the size of the ischemic region upon the the pECG biomarkers can
be observed, only for two representative features, in Figs 6 and 7 for the magnitudes and ratio
of change, respectively. These figures show two different trends as a function of the size of the
ischemic region. First, the biomarkers that depend on depolarization (i.e. QRS amplitude, QT
interval and QRS duration) increased, or decreased, linearly with respect to the size of the
Fig 2. Biomarkers of single cell ePoMs. The image shows the biomarkers measured at 600 ms cycle length. (A) Action
potential duration at 90% repolarization, (B) resting membrane potential and (C) action potential amplitude.
https://doi.org/10.1371/journal.pone.0220294.g002
Fig 3. Biomarkers of cable ePoMs, size of the ischemic region: 2 cm. The boxplots include the biomarkers measured
on all the cells of the cable. (A) Action potential duration at 90% repolarization, (B) resting membrane potential, (C)
action potential amplitude and (D) Conduction velocity.
https://doi.org/10.1371/journal.pone.0220294.g003
Modeling and machine learning for ECG feature engineering
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Fig 4. Pseudo-ECG biomarkers of cables of ePoMs, ischemic region: 2 cm. (A) ST deviation, (B) QRS amplitude, (C)
T wave amplitude, (D) QT interval, (E) QRS complex duration and (F) T wave duration.
https://doi.org/10.1371/journal.pone.0220294.g004
Fig 5. Ratio of change of pseudo-ECG biomarkers of cable ePoMs, ischemic region: 2 cm. (A) ST deviation, (B)
QRS amplitude, (C) T wave amplitude, (D) QT interval, (E) QRS complex duration and (F) T wave duration.
https://doi.org/10.1371/journal.pone.0220294.g005
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ischemic region. Second, the magnitudes, or ratio of change, of the biomarkers measured after
the depolarization ends (i.e. ST deviation, T wave amplitude and T wave duration) had a para-
bolic shape with respect to the size of the ischemic region. The results for all the features can
be consulted in the Supporting Information (S2 File).
Fig 6. Pseudo-ECG biomarkers of TP06 cables of cells as a function of the size of the ischemic region. (A) ST deviation, (B) QT interval.
https://doi.org/10.1371/journal.pone.0220294.g006
Fig 7. Ratio of change of pseudo-ECG biomarkers of TP06 cables of cells as a function of the size of the ischemic region. (A) ST deviation, (B) QT interval.
https://doi.org/10.1371/journal.pone.0220294.g007
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Neural networks classification performance
The database of TP06 Control, Mild (2 cm) and Severe (2 cm) models, which included variabil-
ity, created by means of populations of models enabled the training of the ANNs that would
detect and classify ischemic events. The results of training the ANNs are presented in Table 4,
where HL stands for number of hidden layers and HU for number of hidden units per layer.
The cascade of neural networks (ANN21 followed by ANN22) showed higher performance
than the single multi-class classification network (ANN1). Notwithstanding, ANN1 achieved
high performance with significantly less complexity than the combination of ANN21 and
ANN22. Also, the learning rate required to train ANN1 was 20 times smaller than the one
required to train ANN22 and half of that required for ANN21. The significant reduction in
learning rate meant that training ANN1 involved considerably longer times than training the
other two.
Relative importance of pECG features
The relative importance of each feature, for each of the optimal networks in Table 4, is pre-
sented in Table 5. The table shows that the most relevant features for the multi-class classifica-
tion network were the QT interval and the QRS duration, the T wave amplitude was the least
relevant and the other features shared similar importance. In the classification between Control
and ischemia it was the QT interval that was most important, the ST deviation the least impor-
tant and all other features shared equal relevance. Finally, when discerning between Mild and
Severe ischemia, it was the relative variation in amplitude of the QRS and T waves which
proved to be more relevant and the duration of the T wave the least relevant feature.
Discussion
First, the work presented in this paper investigated the role that inter-subject variability, at the
cellular level, plays when detecting ischemia through ECG signals; this was done through a
computational approach, using pseudo-ECGs. Two virtual databases, containing over 6000
models, were constructed by means of an experimentally-calibrated populations of models
approach. The AP and pECG biomarkers measured from the models contained in the database
Table 4. Best performing neural networks.
Network HL HU Se (%) PPV (%) F1-score (%)
ANN1 5 7 94.77 95.52 95.15
ANN21 5 8 99.00 96.28 97.62
ANN22 4 4 100 100 100
https://doi.org/10.1371/journal.pone.0220294.t004
Table 5. Relative importance of the input features in each ANN.
Network ANN1 ANN21 ANN22
QT interval 0.24 0.28 0.15
ST deviation 0.16 0.09 0.12
QRS amplitude 0.14 0.17 0.29
T amplitude 0.09 0.16 0.21
QRS duration 0.21 0.18 0.13
T duration 0.15 0.12 0.09
https://doi.org/10.1371/journal.pone.0220294.t005
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were in concordance with various simulation and experimental data [19, 43–46]. To the best
of our knowledge, this is the most comprehensive simulation database for the study of acute
ischemia to date, it includes cellular-level variability and contains information about the pres-
ence of ischemia, its severity and its effect on the ECG. Second, this study has introduced the
use of simulation data to validate proof-of-concept neural networks that could, with further
research, inform subsequent clinical studies in the early detection of ischemic events using
ECG biomarkers; this approach had been, to date, unexplored. The analysis of the neural net-
works highlighted the importance of using multiple biomarkers and complex features for the
detection of ischemic events and shed light on which are those that should be monitored for
early detection. The mathematical models and machine learning techniques developed
throughout this study will enable further research in the detection and prevention of myocar-
dial ischemia.
ePoMs reproduce physiological variability under control and ischemic
conditions
Two virtual databases were constructed using experimentally-calibrated populations of mod-
els, one using TP06 models and the other using ORd models. The results presented in the pre-
vious section indicate that the models contained in these databases reproduce the healthy
behavior of cardiac myocytes and the evolution of an ischemic event within those individual
models. Furthermore, the ePoM approach enabled the introduction of inter-subject variability
in those virtual databases, thus making them closer to what would be found in a clinical study.
The results also show that variability has an additive effect, i.e. a relatively small variability in
AP biomarkers resulted in larger variability in pECG biomarkers.
Table 3 shows that the AP biomarkers of the Control ePoMs were within the values expected
in healthy cells. Additionally, the pECG biomarkers were consistent with those previously pre-
sented by Gima and Rudy [19]. Hence, it can be argued that both of the Control ePoMs were,
indeed, a good representation of a healthy population. Furthermore, even though the popula-
tions were constrained to a specific range of APD90, the Control biomarkers (see Table 3) vary
within individual models; this is the effect of including inter-subject variability.
Fig 2 exemplifies how AP biomarkers were affected during ischemic events whilst still
showing inter-subject variability. Namely, the impairment in ICaL and introduction of hypoxic
effects (through Ik(ATP)) produced a clear reduction in action potential duration, the increase
in extra-cellular potassium translated in an increase in RMP and the reduction of the INa cur-
rent caused a clear reduction in APA. Furthermore, Fig 4 shows that the variations from the
Control values observed in the ischemic pECG biomarkers were similar to those described in
clinical practice. Namely, the Mild and Severe ePoMs showed ST segment deviation [43, 45],
reduction in QT interval [43, 44] and T wave deformation [45–47]. The variability observed at
the cellular level during the ischemic events was relatively small, Fig 2 shows little overlap in
the values of APD90 and RMP. However, the additive effect of variability can be clearly
observed in Figs 3 and 4, where there is a larger overlap in the values of conduction velocity
and pECG biomarkers.
These results are consistent with previous pECG studies [14, 16, 17, 19] and with well-
known effects of ischemia on humans [43–46]. So it can be argued that the variability con-
tained in the ePoMs is a faithful representation of the actual variability observed in humans.
One of the key contributions of this work is providing two virtual databases that model the
evolution of ischemic events, where each model represents different physiological conditions.
These databases could be used in future studies to find relationships between ionic current var-
iabilities, ischemia and pECG biomarkers.
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Variability precludes the classification of ischemia through a single
biomarker
Our results suggest that variability makes it impossible to determine both the presence and
severity of ischemia through a simple analysis of the values observed in the pECG biomarkers,
which was the first hypothesis of this work. This is a consequence of the additive effect of vari-
ability, the ECG signal is produced from the aggregation of the electrical responses of many
individual cells, so the relatively small variability observed in cellular biomarkers (i.e. APD90,
APA and RMP) is magnified when measuring the ECG biomarkers.
In Fig 2, one can observe that the 1st and 3rd quartiles of the distributions (i.e. the upper
and lower limits of the boxplots boxes) of APD90 and RMP showed no overlap. Hence, the dif-
ferent ischemic severities could be classified, at the cellular level, by means of thresholds; but
these measurements are not routinely made in patients. Fig 4 shows that all the measured
pECG biomarkers presented overlap in the 1st and 3rd quartiles when comparing Control to
Mild or Mild to Severe. So, it is concluded that the additive effect of variabilities makes it diffi-
cult to draw the lines that classify between the different populations. For example, QRS com-
plex prolongation was observed in some Mild ischemic pECG signals, but the same effect was
only observed in Severe cases of other models. This early QRS complex prolongation was
observed in models that had a weak INa and/or ICaL in their Control values. These can be
regarded as examples of particularly vulnerable patients in which a clinician might have mis-
takenly diagnosed a Severe ischemic event when, in reality, it was Mild. If, alternatively, the
Mild models were used as the classification gold-standard, all other patients would be diag-
nosed late.
An additional source for variability, that confuses the classification of ischemic events, can
be observed in Figs 6 and 7. The biomarkers that measured the QRS complex behaved linearly
whilst the ones that measured the T wave behaved parabolically with respect to the size of the
ischemic region. These behaviors emerged because the QRS complex mainly depends on the
velocity of the depolarizing wave, and the larger the ischemic region, the greater is the fiber’s
depolarization time. Alternatively, the differences in T wave morphology are produced by the
dyssynchrony in the repolarization of the cells along the fiber, so the fibers where repolariza-
tion was more homogeneous (i.e. those where the ischemic and non-ischemic regions had sim-
ilar size) had similar T wave markers.
One can observe, from Fig 5, that inter-subject variability did not preclude a threshold-
based classification when analyzing the ratio of change in the biomarkers; this is because the
ratio of change is a more complex feature than the magnitude and, consequently, carries more
information. Nevertheless, this did not resolve the problem of determining if the pECG that
was being observed corresponded to a healthy heart or to a diseased one. Also, using the ratio
of change makes it necessary to have control values for a patient so one can determine if the
biomarker has changed and, intuitively, determining a baseline value for a patient is not at all
trivial. Furthermore, the variability introduced by considering a variable size for the ischemic
region still made it impossible to define clear thresholds or rules, even when assessing the the
ratio of change in the biomarkers (see Figs 6 and 7).
It is important to highlight that in the simplified case of a homogeneous cable of cells, the
features measured in the pECG are a direct consequence of those measured in the individual
cells. For example, the QRS duration is simply an inverse measure of the conduction velocity
and the QRS amplitude is a result of combining the APA and the CV. However, once the ische-
mic formulation is included, this analysis does not hold anymore. This is particularly evident
from the different behaviors observed in Fig 6, where the size and severity of the ischemic
region introduce non-linear relationships in the behavior of the pECG. Consequently,
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classification of ischemia becomes no longer trivial. Another key contribution of this paper is
to present, through the use of pseudo-ECGs, that the variability originated at the cellular level
is amplified when measuring ECG biomarkers, so simple threshold rules and visual inspection
of signals will, invariably, result in poor detection and classification performance.
Machine learning is effective in detecting and classifying ischemic events
On the one hand, the logistic regression classifiers, used as baseline, had poor performance in
classifying Control or Mild models, they were only good when a Severe model was presented
(please refer to S1 File for details), demonstrating that more advanced classifications algorithms
are required. On the other hand, the neural network models produced high performance in all
the classification tasks. It can be observed from the two classification paradigms that it was pos-
sible to use the pseudo-ECG features to classify the evolution of an ischemic event in a popula-
tion of fibres. The first proposed approach (multi-class classification) proved to have good
performance in assessing the severity of the ischemic event. The second classification topology
presented improved performance over the first one, this can be regarded as a consequence of it
using more complex features when distinguishing between Mild and Severe models. Further-
more, the latter topology had added robustness in the detection: if the first network produced a
false positive, the second one could filter it by observing no change in the magnitude of the bio-
markers, and false negatives were counteracted by the improved sensitivity.
The main advantage in learning the multi-class classification model is that it does not
require patient history and it uses ECG biomarkers that can be easily acquired in a routine
visit to the specialist consultant. However, incorrect classification was observed when the net-
work was applied to models that are severe outliers; this was translated in relatively low sensi-
tivity when compared to the second architecture. In the second scheme, the severity of
ischemia was assessed by taking into account the changes in biomarkers within the model,
hence, it can be regarded as a network that monitors the patient’s condition over time. The
drawback of the cascade of ANNs is that it requires a history for the patient so that a control
set of values can be established; moreover, it is not trivial to establish what this control value
should be for a given patient and it is bound to change over time depending on parameters
that may be too complex to model (e.g. lifestyle, ageing or co-morbidities).
Relevance of pECG features in the detection and classification of ischemic
events
Our results suggest that the use of several biomarkers is convenient when detecting and classi-
fying ischemic episodes, as has been highlighted by previous research [48]. This is mainly
because the biomarkers that were relevant for detection were not the same as those relevant for
classification.
Clinical studies have previously shown that QT shortening is observed in the first 12 hours
after the onset of acute myocardial infarction [43, 49] and Table 5 shows that the classification
between Control and ischemia is mainly driven by the QT interval. Consequently, the results
indicate that QT shortening should be the main cause for alarm in applications that monitor
acute myocardial ischemia. However, this feature became less relevant when discerning
between the Mild and Severe ischemic signals. The results indicate that the relative variation in
the amplitude of the QRS complex and T waves are the features that will play an important
role in determining the severity of the ischemic event. Additionally, in the three networks
there were at least three features of equal importance which, combined, were responsible for at
least 40% of the classification. This means that even if a ‘heavy’ feature is absent or mistaken
the classification can be made using the other features.
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Interestingly, the gold-standard for ischemia detection (i.e. ST segment deviation) may not
be well suited for detecting ischemia at an early stage. Fig 4 indicates that its value under Mild
ischemic conditions was similar to that observed in Control models and Table 5 confirms that
the ST deviation is the least relevant feature when classifying between the Control and the
ischemic cases (ANN21). Consequently, our results imply that, using the network architectures
presented here, ST deviation only becomes relevant in the later stages of acute ischemia, when
discerning between the Mild and Severe ischemic cases.
A framework for testing proof-of-concept ischemia-detection methods
An additional contribution of this work was to prove that non linear functions constructed
using machine learning techniques are capable of producing high classification and detection
performance in an environment plagued by inter-subject variability. This has validated the use
of the presented neural network architectures as a proof-of-concept for the early detection of
ischemic events. Given the results, we can hypothesize that classification using machine learn-
ing models would be beneficial to the diagnosis and classification of acute myocardial ische-
mia. Indeed, the results shown in Tables 4 and 5 indicate that the AI models are capable of
learning which pECG features are more relevant for the classification of the signal and, conse-
quently, are capable of performing the task with higher accuracy.
The results presented here are still far from being applied in clinical practice. However, the
results presented in this publication could be used as a guide for future works that may bring
this approach closer to the clinic. As shown by the results, determining a patient-specific base-
line value for ECG biomarkers should be the matter of further research because it could dramat-
ically improve the detection of early-stage ischemia; indeed, the use of these, more complex,
features enabled a significant increase in performance when compared to the multi-class classi-
fier. Also, our results indicate that QT interval and QRS duration are more relevant for the
detection of acute ischemic events; then, further studies should focus on further exploting these
results and, subsequently, on making robust detection methods for these features because they
are most-likely to have an impact on the AI models’ decision process. Finally, this study supports
the use of computational, population-based, methods for testing proof-of-concept classification
models when there are few data available and the introduction of machine learning techniques
to aid clinicians when diagnostic methods are highly affected by inter-subject variability.
Limitations
It is important to acknowledge that a 1D cable model entails a number of limitations because
one is neglecting the effects of the 3D geometry, particular Purkinje activation sequences, the
effects of chest anatomy, and so on. However, simplifying the pECG calculation to a 1D cable
is necessary this case to make the population study tractable (i.e. simulating thousands of dif-
ferent ischemic conditions is currently impossible to perform, tractably, in a full-heart geome-
try). Also, the simplification of a homogeneous cable for the “healthy” case is necessary
because of the nature of the mathematical models used. Both the TP and ORd models distin-
guish the epi, endo and M cells only by variations of their parameters. Since the ePoM explores
variability through a variation of the parameters of the models, making a heterogeneous cable
of cells may produce undesired confounding factors (e.g. ending up with epicardial cells at the
beginning of the cable or with endocardial cells at the end). Given that the purpose of this
study is to validate the use of computational models as a means to train machine learning algo-
rithms, the aforementioned limitations are justifiable in this context.
Previous works have shown that the pseudo-ECG is capable of simulating real-life physiol-
ogy and pathology [14, 16, 19], however, there are still some limitations concerning the clinical
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translation of the results presented in this work. First, the use of fibres of cells instead of
whole-heart models means that the results obtained in this paper do not account for certain
phenomena that can be observed in an ischemic heart; e.g. re-entrant circuits that lead to
arrhythmia, changes in the direction of electrical propagation because of conduction block in
the ischemic zone, patient-specific Purkinje activation sequences, 3D geometry-related vari-
ability and variations in the ECG depending on the position of the affected area and the char-
acteristics of the patient’s torso. Second, the computational study gives the advantage of a
noise-free environment that makes it simple to measure the pECG features; in a real-life acqui-
sition, the quality of the acquired signal, and of the denoising techniques, will play an impor-
tant role in measuring the biomarkers and is expected to have an impact in the performance of
the machine learning models.
Also, an additional limitation is that, since only the last beat of each model is used, temporal
variations in the ECG (e.g. due to cell-to-cell uncoupling) are not accounted for when training
the machine learning methods; these could play an important role in the generalization of the
models. Moreover, the results revealed that the relative variation in amplitude of the QRS com-
plex and T wave are important to determine the severity of the ischemic event, but in patients
this variation may be due to a change in thoracic morphology (e.g. because of weight loss/
gain) instead of a pathological variation. Additionally, the only consequence of CHD that we
can model nowadays is ischemia, which is not always present in CHD; further research is
required if we hope to use approaches like the one shown here to detect every possible CHD
case.
Finally, only Deep Learning algorithms were used for classification; although these are
known to be universal approximators [50] and optimal classifiers [35], their interpretability is
limited. Other ML approaches that may be more interpretable (e.g. Bayesian methods, support
vector machines, decision trees) could be tested and their performance compared. These limi-
tations will be addressed in future works, where real-life ECG databases will be used in concert
with the simulated data presented here to validate these results and to create robust systems for
the detection and assessment of severity of ischemic events.
Conclusion
This paper has presented the creation of two virtual databases that contain models which cap-
ture the evolution of ischemic events in cardiac cells and include inter-subject variability. The
databases were constructed using ‘experimentally-calibrated populations of models’. Further-
more, these virtual databases were used to train machine learning algorithms capable of detect-
ing and classifying ischemic events with high performance. The entries of the databases
include single cell Control, Mild ischemic and Severe ischemic models and cable Control, Mild
ischemic and Severe ischemic models with varying sizes of the ischemic region. The study pre-
sented in this paper represents progress in the use of experimentally-calibrated populations of
models as a means to investigate coronary heart disease. Four key contributions can be
highlighted from this work. (1) The study on variability presented here would have been
impossible to perform clinically; finding healthy individuals exemplifying all the physiological
conditions contained in the Control ePoMs is unfeasible and inducing ischemia in these
patients is unethical. (2) This paper has shown that the additive effect of variability precludes
the detection and classification of ischemic events using simple thresholds or visual inspection;
non-linear classifiers, capable of automatically assessing ECG signals, must be introduced as a
means to help clinicians when diagnosing coronary heart disease. (3) Our results have shown
that machine learning techniques could be a valid tool to solve the aforementioned challenge
and have validated two different proof-of-concept neural network architectures that could be
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used in a future clinical study. (4) The analysis of the different neural network topologies
revealed that the biomarkers that better detect ischemia and those that better assess its severity
are different, so a multi-biomarker analysis is essential; in particular, future clinical studies
should focus on how to determine a Control value for the biomarkers because calculating their
ratio of change can significantly improve ECG classification. The synthetic databases and
machine learning methods presented here form an important precedent because they can be
used as a step prior to a clinical study where significant challenges may arise and identifying
the sources for errors may be more complicated. The use of virtual databases to explore the
effects of ischemia on cardiac cells and to validate proof-of-concept models for the early detec-
tion of coronary heart disease could give valuable information prior to a clinical study, thus
saving time and speeding-up the applicaton’s development process.
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